The toxicity of cyanobacterial toxins in the mouse: II Anatoxin-a

  title={The toxicity of cyanobacterial toxins in the mouse: II Anatoxin-a},
  author={John K Fawell and Robin E. Mitchell and R E Hill and David J. Everett},
  journal={Human and Experimental Toxicology},
  pages={168 - 173}
Blooms of cyanobacteria are known to have caused poisoning in fish, waterfowl, animals and man. One of the low molecular weight toxins responsible for this is the neurotoxin anatoxin-a which has been detected in reservoirs used for domestic water supplies. While the acute behaviour of this alkaloid is clear, there is uncertainty regarding the effects on man of ingestion of anatoxin-a at low levels over longer periods. In order to assess this risk, a series of in vitro and in vivo experiments… 

Figures and Tables from this paper

Potential developmental toxicity of anatoxin‐a, a cyanobacterial toxin
The current studies were conducted to examine the effect of in utero exposure on postnatal viability, growth and neurodevelopment, to evaluate the potential of in vitro embryotoxicity, and to explore the synergistic relationship between anatoxin‐a and the algal toxin microcystin‐LR by the oral route.
Toxicity, transfer and depuration of anatoxin-a (cyanobacterial neurotoxin) in medaka fish exposed by single-dose gavage
Non-targeted metabolomics investigations performed on the fish liver indicates that the single sub-acute exposure by gavage induces noticeable metabolome dysregulations, including important phospholipid decreases, with an organism recovery period of above 12-24h.
Toxic effects of pure anatoxin-a on biomarkers of rainbow trout, Oncorhynchus mykiss.
Risk Assessment of Anatoxin-A
The aim of this work is to accomplish the risk assessment of anatoxin-a, by approaching three main steps of this process: hazard identification and characterization, exposure assessment, and risk characterization, since the presence of Anabaena sp.
Risk to human health associated with the environmental occurrence of cyanobacterial neurotoxic alkaloids anatoxins and saxitoxins
This review reports and analyzes the available literature data on environmental occurrence of cyanobacterial neurotoxic alkaloids, namely anatoxins and STXs, their biosynthesis, toxicology and epidemiology, derivation of guidance values and action limits, used as the basis to assess the risk posed to human health, identify critical exposure scenarios and highlight the major data gaps and research needs.
Cyanotoxins: producing organisms, occurrence, toxicity, mechanism of action and human health toxicological risk evaluation
The properties of the most frequently detected cyanotoxins (namely, microcystins, nodularins, cylindrospermopsin and neurotoxins) are reviewed, describing for each toxin the available information on producing organisms, biosynthesis/genetic and occurrence with a focus on the toxicological profile.
Co-occurrence of the Cyanotoxins BMAA, DABA and Anatoxin-a in Nebraska Reservoirs, Fish, and Aquatic Plants
Investigation of the occurrence and potential for bioaccumulation of cyanotoxins in several Nebraska reservoirs found measurable levels of these neurotoxic compounds were detected in approximately 25% of the samples, with detections of BMAA, DABA, and anatoxin-a.


Effect of route of exposure and repeated doses on the acute toxicity in mice of the cyanobacterial nicotinic alkaloid anatoxin-a.
  • D. Stevens, R. Krieger
  • Biology, Medicine
    Toxicon : official journal of the International Society on Toxinology
  • 1991
Algae intoxication in livestock and waterfowl.
Evaluation of the subacute toxicity and teratogenicity of anatoxin-a.
Anatoxin-a: a novel, potent agonist at the nicotinic receptor.
Evidence is concluded that anatoxin-a does not block the open ion channel and does not produce a voltage-dependent blockade of the closed ion channel, and the activity of this unusual agonist may be related to the coulombic and hydrogen bond free energies of binding to the receptor.
(+)‐Anatoxin‐a Is a Potent Agonist at Neuronal Nicotinic Acetylcholine Receptors
In these diverse preparations, (+)‐anatoxin‐a was between three and 50 times more potent than (–)‐nicotine and ˜20 times more powerful than acetylcholine, making it the most efficacious nicotinic agonist thus far described.
Cardiovascular effects of anatoxin-A in the conscious rat.
Cardio-respiratory changes and mortality in the conscious rat induced by (+)- and (+/-)-anatoxin-a.
  • O. Adeyemo, A. Sirén
  • Biology
    Toxicon : official journal of the International Society on Toxinology
  • 1992
Alkyl‐modified side chain variants of anatoxin‐a: A series of potent nicotinic agonists
A series of alkyl‐modified analogues based on anatoxin‐a provides some novel potent nicotinic agonists and with propylanatoxin, receptor subtype selectivity may be emerging.
Electromyographic assessment of the neuromuscular blockade produced in vivo by anatoxin-a in the rat.